United States

Back to map

Showing 101-110 of 354 grants

Title Institution Researcher Program Duration Total Award Amount
Study of ALDH3B2 as a regulator of pancreatic beta cell neogenesis Joslin Diabetes Center Inc. Jian Li Cures 01-August-2023 to 31-July-2026 $212,708.89
Effectiveness and safety of sotagliflozin in slowing kidney function decline in persons with type 1 diabetes and moderate to severe diabetic kidney disease: The SUGARNSALT Trial Joslin Diabetes Center Inc. Alessandro Doria Improving Lives 01-January-2024 to 31-December-2028 $8,913,450.00
Innovation Partnership LabCentral Luke Wallrich Cures 15-May-2026 to 31-May-2027 $200,000.00
Assessment of NovoSphere™ Hydrogel Encapsulation to Enable High-Loading and Extended Release of Tegoprubart for Subcutaneous Administration Likarda, Inc Lisa Stehno-Bittel Cures 15-June-2026 to 15-December-2026 $301,200.00
Transcriptional memory in human islet organogenesis Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) Eiji Yoshihara Cures 01-April-2022 to 31-March-2027 $749,995.50
INHALE-1st: Technosphere Insulin (Afrezza®) In Combination With Basal Insulin For Youth With Newly-Diagnosed Type 1 Diabetes Mannkind Ian Buckner Improving Lives 25-June-2026 to 24-June-2028 $600,000.00
Development and testing of protease-resistant CXCL12 loaded sub 100 micron polymeric microbeads to enable alloislet transplantation without systemic immune suppression in established murine models of type 1 diabetes Massachusetts General Hospital Mark Poznansky Cures 01-February-2026 to 31-January-2028 $599,448.76
Development of a safe and effective islet-targeted nanoplasmid based CXCL12 gene delivery system using cationic nanobubble-mediated sonotransfection to restore and immune protect the residual beta cell mass in T1D Massachusetts General Hospital Mark Poznansky Cures 01-April-2023 to 31-March-2027 $777,168.00
Epithelial Immune Sentinels in T1D Autoimmune Kidney Disease Massachusetts General Hospital Maria Agustina Battistone Improving Lives 01-September-2026 to 31-August-2028 $189,099.97
Understanding common tissue tolerance mechanisms in autoimmunity Massachusetts General Hospital Gary Reynolds Cures 01-September-2025 to 28-February-2027 $150,000.00